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ax and Bak play a redundant but essential role in
apoptosis initiated by the mitochondrial release of
apoptogenic factors. In addition to their presence at
 
the mitochondrial outer membrane, Bax and Bak can also
localize to the ER. Agents that initiate ER stress responses
can induce conformational changes and oligomerization of
Bax on the ER as well as on mitochondria. In wild-type cells,
this is associated with caspase 12 cleavage that is abolished
 
in 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 cells. In 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 
 
cells, introduction of
Bak mutants selectively targeted to either mitochondria or
B
 
the ER can induce apoptosis. However, ER-targeted, but
not mitochondria-targeted, Bak leads to progressive depletion
 
of ER Ca
 
2
 
 
 
 and induces caspase 12 cleavage. In contrast,
mitochondria-targeted Bak leads to enhanced caspase 7
and PARP cleavage in comparison with the ER-targeted
Bak. These ﬁndings demonstrate that in addition to their
functions at mitochondria, Bax and Bak also localize to the
ER and function to initiate a parallel pathway of caspase
activation and apoptosis.
 
Introduction
 
A eukaryotic cell is a well-integrated unit that consists of a
number of subcellular organelles, such as nucleus, mito-
chondria, the ER, the Golgi apparatus, and lysosomes. These
organelles function in an organized fashion to maintain intra-
cellular homeostasis. Each organelle possesses sensors that
detect specific cell death–inducing signals and activate different
signal transduction pathways, which in turn lead to the ulti-
mate apoptotic events involving the mitochondrial mem-
brane permeabilization and/or the caspase activation cascades
(Ferri and Kroemer, 2001).
The ER is the cytoplasmic compartment where proteins
and lipids are synthesized and modified. Due to the presence
of high concentrations of protein, numerous protein chap-
erones exist in the ER. These chaperones facilitate the
proper folding of proteins, or maintain proteins in a folding-
competent state and prevent protein folding intermediates
from aggregating. In response to a number of stimuli that
 
disrupt ER function, such as Ca
 
2
 
 
 
 depletion from the ER
lumen, inhibition of asparagine (N)-linked glycosylation,
reduction of disulfide bonds, or overexpression of some
proteins, protein misfolding occurs and unfolded proteins
accumulate and aggregate in the ER. The misfolded and
aggregated proteins then trigger the unfolded protein response
(UPR).* Under less severe situations, UPR results in the
reduction of general protein synthesis and selectively acti-
vates the expression of proteins facilitating the chaperone
function (Kaufman, 1999). Under conditions of severe
ER stress that the cells are not able to adapt to, UPR trig-
gers apoptosis. UPR-induced apoptosis is associated with
the up-regulation of the transcriptional factor CHOP/
GADD153 and with eIF-2
 
 
 
 phosphorylation (Kaufman,
1999), which may lead to the activation of a caspase cas-
cade that involves the ER-specific caspase 12 (Nakagawa et
al., 2000).
Bcl-2 family proteins play essential roles in regulating
apoptosis. Whereas some members of the Bcl-2 family antag-
onize cell death, others exhibit proapoptotic activities. Bax
and Bak are the proapoptotic members of the Bcl-2 family
that are ubiquitously expressed in different tissues. They
reside in the cytosol or on mitochondria and are kept in an
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inactive form in healthy cells. Overexpression of the multi-
domain death-promoting Bax-like proteins results in cell
death in both mammalian and yeast cells (Oltvai et al.,
1993; Chittenden et al., 1995; Hanada et al., 1995; Green-
half et al., 1996; Jurgensmeier et al., 1997). When a cell is
committed to apoptosis, Bax and Bak undergo conforma-
tional change, leading to their oligomerization and insertion
in the mitochondria outer membrane (Hsu et al., 1997;
Gross et al., 1998; Desagher et al., 1999; Griffiths et al.,
1999; Wei et al., 2000; Makin et al., 2001). This process is
followed by the release of cytochrome c from mitochondria
to the cytosol. Cytochrome c binds to Apaf-1 and caspase 9,
resulting in the activation of caspase 9, the subsequent acti-
vation of caspases 3 and 7, and ultimately cell death. Studies
of the Bax/Bak doubly deficient mice indicate that the mul-
tidomain proapoptotic Bax and Bak proteins are required
for mitochondria-mediated cell death (Lindsten et al., 2000;
Wei et al., 2001; Zong et al., 2001).
Figure 1. Bax and Bak are localized to the ER in addition to their mitochondrial location. (A) Wild-type and bax
 / bak
 /  MEFs as well as 
HeLa cells were resuspended in hypotonic buffer A and disrupted. Subcellular fractionation was performed to obtain the fractions for cytosol 
(S-100), HM (mitochondria enriched), and LM (the ER enriched). 20  g of total protein from each fraction was separated on a 4–12% gradient 
NuPAGE gel. Antibodies against Bax, Bak, calnexin, and Cox IV were used for immunoblotting. (B) Mouse liver was homogenized in buffer A 
and fractionated in sucrose gradient as described in the Materials and methods. Fractions from crude mitochondria and the 1.5/1.8 M sucrose 
interface were probed with indicated antibodies. (C) The LM fraction was not contaminated by mitochondrial outer membrane. Fractions of 
wild-type MEFs were probed with an anti-Tom40 antibody. (D) Immunoelectron microscopy of Bax (left) and Bak (right) in wild-type MEFs 
using 10-nm gold particles. The bottom panels are the enlargements of the boxed areas of the top images. The arrowheads point to the ER. 
mt, mitochondria.T
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Although intensive studies have been focusing on how
Bcl-2 family proteins regulate apoptosis at the mitochondria
level, evidence exists that Bcl-2 proteins may also function at
the ER level. In addition to mitochondria, Bcl-2 is also
found in the ER membranes (Cleary and Sklar, 1985; Kra-
jewski et al., 1993; Akao et al., 1994; Lithgow et al., 1994;
Nguyen et al., 1994). Overexpression of Bcl-2 and Bcl-xL
blocks thapsigargin-induced apoptosis (Srivastava et al.,
1999). A Bcl-2–cytochrome b5 (cb5) mutant selectively tar-
geted to the ER blocks apoptosis induced by ER stress re-
sulting from tunicamycin and brefeldin A treatment (Hacki
et al., 2000; Annis et al., 2001). This ER-targeted Bcl-2 mu-
tant also protects cells from Bax-induced cell death (Wang et
al., 2001). Fibroblasts lacking both Bax and Bak are resistant
to ER stress–induced apoptosis, and ectopic expression of
Bax in these doubly deficient cells restores their sensitivity
(Wei et al., 2001; Zong et al., 2001). These findings suggest
that Bax and Bak can either sense the ER damage and func-
tion on mitochondria to induce mitochondrial membrane
permeabilization–mediated apoptosis, or that there exists an
unknown function of Bax and Bak at the ER level. In the
present study, we report that the multidomain proapoptotic
Bax and Bak proteins also reside at the ER in addition to
their mitochondrial localization. ER stress can induce con-
formational changes and oligomerization of Bax and Bak on
the ER membrane. ER stress–induced cleavage of the ER-
specific caspase 12 is dependent on Bax and Bak. Targeted
expression of Bak in the ER results in ER Ca
 
2
 
 
 
 depletion,
caspase 12 processing, and ultimately cell death. These find-
ings indicate that in addition to their roles on mitochondria,
Bax/Bak proteins may also be involved in initiating apopto-
sis from the ER.
 
Results
 
Bax and Bak are localized to the ER 
in addition to mitochondria
 
Antiapoptotic Bcl-2 proteins have been found in the ER/nu-
clear envelope in addition to their localization in mitochon-
dria (Krajewski et al., 1993; Akao et al., 1994; Nguyen et al.,
1994). It remains unclear whether the proapoptotic proteins
Bax and Bak also reside and function at the ER. Subcellular
fractionation was performed in wild-type murine embryonic
fibroblasts (MEFs), 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 MEFs, and HeLa cells. In
agreement with previous reports, Bax was found in the cyto-
solic S-100 fraction, as well as in the mitochondria fraction
(heavy membrane [HM]). Bak was found in the mitochon-
drial fraction but not in the cytosol. Despite their differential
appearance in the cytosol, both Bax and Bak were found in
the ER/microsome fraction (light membrane [LM]) (Fig. 1
A). To further demonstrate the subcellular localizations of
Bax and Bak, crude mitochondria from mouse liver were
fractionated in a 1–2 M continuous sucrose gradient. The
postmitochondria supernatant was fractionated using step
sucrose gradient, and the interface between the 1.5 and 1.8 M
sucrose was collected as heavy microsomes. Similar to the
data shown in Fig. 1 A, there is an enrichment of Bax and
Bak in the ER/microsome fraction (Fig. 1 B). The purity of
different fractions was determined using markers specifically
localized to mitochondria or the ER. The mitochondria frac-
tion was contaminated by the ER membrane during the frac-
tionation procedure, indicated by the presence of the ER
membrane protein calnexin in HM. However, the S-100
and LM fractions were not contaminated by mitochondria,
as indicated by the absence of the mitochondrial inner mem-
brane protein COX IV or mitochondrial outer membrane
Tom40 (Fig. 1 C) in these fractions. An electron micrograph
showed that Bax-specific gold labels were associated with the
ER and cytosol, and that those of Bak were associated with
the ER and mitochondria (Fig. 1 D). These results were spe-
cific, as no immunogold labeling was observed in samples of
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 MEFs processed at the same time (unpub-
lished data). Together, these findings demonstrate that in
addition to their location on mitochondria, Bax and Bak also
reside in the ER/microsome subcellular compartments.
 
ER stress induces Bax and Bak conformational changes
 
It has been established that during apoptosis, Bax and Bak
undergo conformational change. This process seems to be
required for the proapoptotic activity of Bax and Bak (Hsu
et al., 1997; Gross et al., 1998; Desagher et al., 1999; Grif-
fiths et al., 1999; Wei et al., 2000; Makin et al., 2001). To
determine whether these proapoptotic proteins also undergo
conformational changes during ER stress–induced apopto-
sis, HeLa, MCF7, and 293T cells were treated with thapsi-
gargin and tunicamycin. These drugs trigger ER-mediated
apoptosis by perturbing the normal function of the ER.
Thapsigargin inhibits the ER Ca
 
2
 
 
 
 uptake from the cytosol.
Tunicamycin is an inhibitor of protein N-glycosylation. An-
tibodies against Bax and Bak that recognize their proapop-
totic-competent forms were used. These antibodies were
previously used to demonstrate the activation of Bax and
Bak in response to other apoptotic stimuli (Griffiths et al.,
1999; Mandic et al., 2001). In all three cell lines tested, ER
stress treatment resulted in an increase of the active forms of
Bax and Bak, indicating that Bax and Bak undergo confor-
mational changes from the inactive forms to the active forms
upon ER stress treatment (Fig. 2 A).
 
ER stress induces Bax oligomerization on the ER
 
Accompanying the conformational changes, Bax and Bak
undergo oligomerization on the mitochondrial outer mem-
brane. As Bax and Bak proteins also exist on the ER mem-
brane (Fig. 1), and they undergo conformational changes
upon ER stress treatment (Fig. 2 A), we examined whether
these proteins oligomerize on the ER membrane. Wild-type
MEF cells were treated with thapsigargin, tunicamycin, or
brefeldin A, which is another ER stress agent that blocks the
ER–Golgi transportation. After the drug treatment, a sulfhy-
dryl-reactive cross-linker bismaleimidohexane (BMH) was
used to cross-link the oligomerized proteins. Cells were frac-
tionated and examined for Bax localization and oligomeriza-
tion. Consistent with Fig. 1, Bax was found in both mito-
chondria and ER fractions. ER stress treatment resulted in
increased accumulation of Bax in both mitochondria and
the ER. Importantly, the amount of oligomerized Bax was
also increased in both mitochondria and the ER, indicated
by increased amounts of slow mobility bands recognized byT
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Bax antibody after treatments (Fig. 2 B). Similar results were
obtained using the NIH3T3 murine fibroblast line (unpub-
lished data). These findings indicate that ER stress can in-
duce the oligomerization of Bax on both mitochondria and
the ER, suggesting that Bax may also function at the ER to
induce apoptosis in response to apoptotic stimuli.
 
Caspase 12 activation is Bax/Bak dependent
 
Caspase 12 is specifically localized to the ER and has been
reported to be cleaved during ER stress–induced apoptosis
(Nakagawa et al., 2000). To investigate whether ER stress–
induced caspase 12 cleavage is dependent on Bax and Bak,
wild-type, 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
, and NIH3T3 cells were treated
with brefeldin A, thapsigargin, and tunicamycin. No consis-
tent differences in total caspase 12 expression were observed
between wild-type MEFs, NIH3T3 cells, and 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
MEFs. However, in both wild-type MEFs and NIH3T3
cells, an 
 
 
 
47-kD fragment was revealed in untreated cells,
indicating that there exists a basal processing of caspase 12 in
these cells, which does not lead to apoptosis (Fig. 3 A). The
ER stress treatment resulted in further caspase 12 cleavage,
shown as the appearance of an 
 
 
 
42-kD fragment in both
wild-type MEFs and NIH3T3 cells. In contrast, the caspase
12 processing was not observed in 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 cells (Fig. 3
A). Interestingly, the UPR-responsive transcriptional factor
CHOP was induced by ER stress treatment in all three cell
lines, including 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 cells, indicating that cells defi-
cient in Bax and Bak are still responding to ER stress–
Figure 2. ER stress induces Bax and Bak conformational 
changes and oligomerization at the ER. (A) ER stresses 
induce the conformational changes of Bax and Bak. HeLa, 
MCF7, and 293T cells were treated with thapsigargin 
(Thap; 2  M) or tunicamycin (Tuni; 5  g/ml) for 36 h. 
Cells were fixed in 0.25% paraformaldehyde in PBS for
5 min. Cells were incubated with a control antibody 
(mouse IgG1) and conformation-sensitive antibodies 
against Bax or Bak, followed by incubation with FITC-
conjugated secondary antibody. (B) ER stress induces Bax 
oligomerization at the ER. Wild-type MEFs were treated 
with brefeldin A (BFA; 10  g/ml), Thap (2  M), or Tuni 
(10  g/ml) for 24 h. Cells were resuspended in hypotonic 
buffer A and disrupted. 5 mM BMH cross-linking reagent 
was added to cross-link the oligomerized proteins. Cells 
were subjected to subcellular fractionation to obtain the 
HM and LM fractions. 20  g of total protein was separated on a 4–12% gradient NuPAGE gel. A polyclonal anti-Bax antibody was used to 
detect Bax. COX IV and calnexin are shown as indicators of the purity of the fractionation and as loading controls.T
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induced UPR (Fig. 3 A). If caspase 12 activation is depen-
dent on Bax and Bak, it can be postulated that the killing ac-
tivity of caspase 12 lies downstream in the apoptotic path-
way initiated by these multidomain proapoptotic Bcl-2
proteins. We examined whether enforced activation of cas-
pase 12 can kill cells deficient in Bax and Bak. As expected,
ectopically expressed caspase 3 and caspase 9 resulted in
apoptosis in both wild-type and 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 MEFs (Fig. 3
B). Similarly, overexpression of full-length and truncated
caspase 12 (t-caspase 12) induced cell death in both wild-
type and 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 cells, and t-caspase 12 had a higher
killing activity than the full-length caspase 12, as previously
described (Fig. 3 B; Nakagawa and Yuan, 2000).
 
Targeting Bak mutants specifically to the ER 
or mitochondria
 
To study the function of proapoptotic Bcl-2 proteins selec-
tively expressed on different intracellular organelles, mutants
containing either mitochondrial- or ER-targeting sequences
were constructed. In these mutants, sequences of the listerial
protein ActA, which specifically directs proteins to mito-
chondria, and that of cb5, which specifically targets proteins
 
to the ER membrane, were used as previously described
(Zhu et al., 1996). Although the carboxy-terminal hydro-
phobic transmembrane domain of Bak is well defined func-
tionally, the membrane-targeting domain of Bax remains
controversial. Therefore, we generated Bak mutants specifi-
cally targeted to mitochondria and the ER by replacing the
carboxy-terminal transmembrane domain of Bak with the
cb5 and ActA sequences (Fig. 4 A). To confirm the respec-
tive subcellular localization of these mutants, the mutant
proteins were tagged with EGFP, and their subcellular local-
ization was examined by microscopy. The Bak mutants were
expressed in MCF7 breast carcinoma cells, which lack cas-
pase 3 and thus exhibit delayed apoptotic kinetics in re-
sponse to Bak transfection, enabling us to look at the subcel-
lular localization of the Bak mutants. GFP-tagged Bak-ActA
resulted in superimposition of Bak’s localization with that
derived from an antibody against COX IV, which is selective
for mitochondria, and areas of clear separation in the stain-
ing pattern for Bak-ActA and the ER protein calnexin. In
contrast, GFP-tagged Bak-cb5 resulted in superimposition
of Bak’s localization and that of calnexin, whereas there were
clear areas of separation of the GFP–Bak-cb5 signals and
those of COX IV (Fig. 4 B).
 
The ER-targeted Bak depletes ER Ca
 
2
 
 
 
To determine whether the ER-targeted Bak or any of the
other Bak mutants can perturb the integrity of the ER
membrane, we determined the effects of these mutants on
the ER Ca
 
2
 
 
 
 store by assessing thapsigargin-induced ER
Ca
 
2
 
 
 
 release. 
 
bax
 
 
 
/
 
 
 
bak
 
 
 
/
 
 
 
 
 
cells were infected with retrovi-
ruses encoding GFP alone, or in combination with wild-
type Bak, Bak-ActA, or Bak-cb5, and analyzed for changes
in intracellular [Ca
 
2
 
 
 
] after thapsigargin treatment. The
thapsigargin-releasable pool of ER Ca
 
2
 
 
 
 was depleted in
cells expressing Bak-cb5 (Fig. 5 A). In contrast, cells in-
fected with GFP alone or GFP plus wild-type Bak or Bak-
ActA showed a significant thapsigargin-induced release of
ER Ca
 
2
 
 
 
 stores, demonstrated by an increase in the cyto-
solic Ca
 
2
 
 
 
 concentration in calcium-free medium, i.e., in
the absence of capacitative Ca
 
2
 
 
 
 entry through the plasma
membrane (Fig. 5 A). To demonstrate that the abolishment
of the thapsigargin-inducible [Ca
 
2
 
 
 
]
 
i
 
 spike is due to the de-
pletion of the ER Ca
 
2
 
 
 
 store in response to Bak-cb5, cells
expressing vector, wild-type Bak, Bak-ActA, or Bak-cb5
were incubated in Ca
 
2
 
 
 
-free buffer. Addition of extracellu-
lar Ca
 
2
 
 
 
 resulted in higher Ca
 
2
 
 
 
 entry through the plasma
membrane in Bak-cb5–expressing cells, indicating that
these cells had lower [Ca
 
2
 
 
 
]
 
ER
 
, thus higher store-operated
Ca
 
2
 
 
 
 entry (Fig. 5 B).
The effect of Bak-cb5 on ER Ca
 
2
 
 
 
 is specific because it is
only the Bak-cb5–positive population that loses the ability
to further release ER Ca
 
2
 
 
 
 in response to thapsigargin. The
GFP-negative (untransduced) population within the same
sample had a normal thapsigargin-induced response (Fig. 5
C). Upon addition of extracellular Ca
 
2
 
 
 
 to the medium after
thapsigargin treatment, rapid Ca
 
2
 
 
 
 influx occurred in both
Bak-cb5–expressing and nonexpressing cells within the same
sample. This demonstrates that the Bak-cb5–positive cells
retain the ability to regulate their intracellular Ca
 
2
 
 
 
 homeo-
stasis to compensate for their unfilled ER Ca
 
2
 
 
 
 stores
Figure 3. Caspase 12 functions downstream of the multidomain 
proapoptotic Bcl-2 family proteins. (A) ER stress–induced caspase 
12 cleavage is dependent on Bax and Bak. Immortalized wild-type 
and bax
 / bak
 /  MEFs and NIH3T3 cells were treated with brefeldin 
A (BFA; 10  g/ml), thapsigargin (Thap; 2  M), or tunicamycin (Tuni; 
10  g/ml) for 30 h. Caspase 12 level and processing were examined 
by immunoblotting of 20  g of total cellular protein from samples 
as indicated. An  42-kD caspase 12 fragment is indicated by the 
arrow. Induction of CHOP expression is shown as an indicator of 
the ER stress response. A nonspecific band (NS) is shown as a loading 
control. (B) Caspase 12 kills bax
 / bak
 /  cells. Wild-type and 
bax
 / bak
 /  MEFs were cotransfected with pEGFP and constructs 
expressing caspase 3, caspase 9, caspase 12, and t-caspase 12. 
24 h after transfection, cells were stained with DAPI, and cell death 
percentage was determined by the ratio of DAPI-positive to GFP-
positive cells.T
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through capacitative Ca
2  entry. In addition, the Bak-cb5–
specific effect on ER Ca
2  is independent of mitochondrial
damage because Bak-cb5–expressing cells retained the same
mitochondrial potential as that of the uninfected cells in the
same culture (Fig. 5 D).
The ER-targeted Bak can induce apoptosis
Expression of wild-type Bak, Bak-ActA, and Bak-cb5 in-
duced apoptosis in wild-type MEFs (Fig. 6), as well as in
HeLa, MCF7, and 293T cells (unpublished data), whereas
the carboxy terminus–deleted Bak- C mutant did not cause
Figure 4. Generation of mitochondrial- and the ER-
targeted Bak mutants. (A) Schemes of the Bak mutants. 
The carboxy-terminal transmembrane domain of Bak was 
deleted ( C) or replaced with the mitochondria-targeting 
sequence of ActA (ActA) or the ER-targeting sequence of cb5. 
(B) Targeting the Bak mutants to mitochondria and the ER. 
Bak mutants were expressed in MCF7 cells. Mitochondria 
marker COX IV and the ER marker calnexin were visualized 
by immunofluorescence. Note that the Bak-ActA mutant 
colocalized with COX IV but not calnexin, and the Bak-cb5 
mutant colocalized with calnexin but not COX IV.
Figure 5. The ER-targeted Bak-cb5 
induces depletion of the ER Ca
2  pool. 
(A) Cells with ER-targeted Bak lack 
thapsigargin-releasable intracellular 
Ca
2 . bax
 / bak
 /  cells were infected 
with retroviruses encoding GFP, Bak-
IRES-GFP, Bak-ActA-IRES-GFP, or Bak-
cb5-IRES-GFP. 48 h after infection, cells 
were loaded with Indo-1, and the ER 
Ca
2  release was measured by flow 
cytometry. Propidium iodide was added 
to determine the cell viability. The Ca
2  
flux traces were derived from gated live 
GFP-positive cells. The [Ca
2 ]i was 
calibrated from the measured Indo-1 
fluorescence ratio as described in the 
Materials and methods. The arrowhead 
indicates the time of thapsigargin addition. 
(B) Expression of ER-targeted Bak depleted 
intracellular Ca
2  storage in the ER. At 
the start of measurement, extracellular 
free Ca
2  concentration was reduced 
to zero. The arrowhead indicates the 
time when the extracellular free Ca
2  
concentration was brought back to 
2 mM. [Ca
2 ]i was analyzed as in A. 
(C and D) bax
 / bak
 /  cells were 
infected with the Bak-cb5-IRES-GFP. 
(C) The measured Indo-1 fluorescence ratio between  405 and  475 is presented as an index of change in cytosolic [Ca
2 ] over time and 
presented separately for gated live GFP-positive (expressing Bak-cb5) or GFP-negative (not expressing Bak-cb5) cells. The absolute [Ca
2 ]i 
in the linear range is indicated on the right. The arrowhead indicates the time of thapsigargin addition. The arrow indicates the time of the 
addition of 8 mM CaCl2 to the medium. (D) Mitochondrial potential in GFP-positive (expressing Bak-cb5, green) and in GFP-negative (not 
expressing Bak-cb5, black) cells was measured by tetramethyl rhodamine ethyl ester (TMRE) staining.T
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cell death. It is possible that the mitochondria- and ER-tar-
geted Bak mutants kill cells by simply breaking the balance
between the endogenous anti- and proapoptotic Bcl-2 fam-
ily proteins. Previous studies have demonstrated that cells
deficient in both Bax and Bak are defective in apoptosis.
Therefore, we expressed the mitochondria- and ER-targeted
Bak mutants in bax
 / bak
 /  cells to examine whether the
multidomain proapoptotic Bak-like proteins can directly
initiate apoptosis at the ER. As shown in Fig. 6 A, wild type
and mitochondria- and ER-targeted Bak mutants all killed
the bax
 / bak
 /  cells (Fig. 6 A). Quantitation of cell death
by DAPI exclusion showed that the ER-targeted Bak has
more potent killing activity than the wild type and the mito-
chondria-targeted Bak in wild-type and bax
 / bak
 /  cells
(Fig. 6 B). This higher ability of Bak-cb5 to induce apopto-
sis when compared with wild-type Bax could not be ac-
counted for by a difference in the level of expression, as
wild-type Bak was consistently expressed at higher levels
than Bak-cb5 after retroviral infection (unpublished data).
These data indicate that in the absence of endogenous
proapoptotic proteins Bax and Bak, the multidomain proap-
optotic Bcl-2 proteins can initiate apoptosis directly from
the ER. Overexpression of Bcl-xL blocked the proapoptotic
activities of all Bak mutants (Fig. 6 B), indicating that these
mutants, including Bak-cb5, induce apoptosis through a
physiological manner that is blockable by the antiapoptotic
molecule Bcl-xL. Interestingly, the killing activities of the
Bak mutants were also blocked by the pan-caspase inhibitor
z-VAD-fmk, suggesting that caspase activation may be in-
volved in the death-inducing activities of these mutants
(Fig. 6 B).
It is interesting to note that the Bak-cb5 mutant induced
apoptosis in a more potent fashion than wild-type Bak and
Bak-ActA (Fig. 6 A). A possible reason is that the replace-
ment of the Bak carboxy-terminal transmembrane domain
with the cb5 sequence may change the protein to its active
death-inducing conformation. To address this possibility,
Bak mutants were expressed in bax
 / bak
 /   cells, with
GFP as a marker expressed from the internal ribosomal en-
try site (IRES) site. At 24 h after infection, when only mar-
Figure 6. The ER-targeted Bak can 
induce apoptosis in the absence of 
endogenous Bax and Bak. Wild-type 
and bax
 / bak
 /  MEFs were infected 
with retroviruses expressing GFP or 
GFP together with wild-type murine 
Bak, Bak-ActA, Bak-cb5, or Bak- C. 
48 h after infection, 1  g/ml DAPI was 
added to stain the apoptotic cells. 
(A) bax
 / bak
 /  cells were photographed 
using a FITC or DAPI filter. (B) The 
percentage of dead cells was determined 
by the ratio of DAPI-positive cells to 
GFP-positive cells. In addition to the 
retroviral infection of the Bak mutants, 
bax
 / bak
 /  cells were also coinfected 
with retrovirus expressing Bcl-xL, or 
infected in the presence of 20  g/ml 
Z-VAD-fmk. Data shown are the average 
of three independent experiments. 
(C) 24 h after infection, bax
 / bak
 /  
cells were trypsinized. A portion of 
each sample was subjected to FACS
® 
to determine the expression efficiency 
indicated by GFP-positive cells. The 
rest of the cells were fixed in 0.25% 
paraformaldehyde and stained with an 
anti-Bak antibody that recognizes the 
active form of murine Bak. The number 
in each dot plot represents the percentage 
of gated events (R1).T
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ginal cell death could be observed, all mutants were ex-
pressed at comparable levels, indicated by GFP-positive
cells. Interestingly, an anti-Bak antibody that recognizes
specifically the active proapoptotic form of Bak revealed
that most of the Bak-cb5–expressing cells had undergone a
conformational change indicative of Bak activation (Fig. 6
C). Thus, the higher death rate in Bak-cb5–expressing cells
may be due to the activated conformation of Bak caused by
alteration of its carboxy terminus in Bak-cb5 and membrane
insertion in the ER.
The ER-targeted Bak mutant specifically induces 
caspase 12, but not caspase 7, cleavage
As caspase 12 cleavage is dependent on Bax and Bak, and the
ER-targeted Bak can lead to apoptosis, we determined
whether expression of the ER-targeted Bak in bax
 / bak
 / 
cells results in caspase 12 processing. Wild-type Bak and the
ER- and mitochondria-targeted Bak mutants were retrovi-
rally expressed in bax
 / bak
 /  MEFs. Expression of Bak-cb5
resulted in cleavage of caspase 12, whereas little caspase 12
cleavage was observed in wild-type Bak–expressing cells, and
virtually no caspase 12 cleavage was observed in Bak-ActA–
expressing cells (Fig. 7). In contrast, expression of either wild-
type Bak or Bak-ActA mutant resulted in cleavage of caspase
7 and PARP, whereas little to no caspase 7 and PARP cleav-
age was observed in Bak-cb5–infected cells (Fig. 7). Thus,
despite the fact that Bak-cb5 induces apoptosis, it does not
appear to activate the mitochondrial apoptosis machinery in
the bax
 / bak
 / cells that lack the mitochondrial Bax and
Bak. Moreover, these findings indicate that increased cleav-
age of caspase 12 in Bak-cb5–expressing cells is not merely
due to higher levels of cell death, but rather that distinct
caspases are selectively activated depending on whether Bak is
localized primarily to the ER or mitochondria.
Discussion
Bcl-2 family proteins play a central role in regulating apop-
tosis. It has been well established that these proteins func-
tion at mitochondria to prevent or promote the release of
apoptogenic factors such as cytochrome c, AIF, Smac/Di-
ablo, endonuclease G, and Omi (Wang, 2001). In addition
to their mitochondrial localization, some antiapoptotic
members of the Bcl-2 family have also been found to be
present at the ER and perinuclear membrane regions, sug-
gesting a role of the Bcl-2 family proteins at sites other than
mitochondria (Cleary and Sklar, 1985; Krajewski et al.,
1993; Akao et al., 1994; Lithgow et al., 1994; Nguyen et
al., 1994). Here we demonstrate that the multidomain
proapoptotic Bcl-2 family members Bax and Bak also reside
at the ER in addition to their mitochondrial localization.
ER stress induces conformational changes and oligomeriza-
tion of these proteins on the ER membrane, which may
lead to a lesion of the ER membrane integrity. The exist-
ence of a Bax/Bak-dependent apoptotic pathway initiated
from the ER may explain the observations that cells lacking
Apaf-1, caspase 9, or cytochrome c showed only attenuated,
but not complete, resistance to certain death stimuli (Cec-
coni et al., 1998; Kuida et al., 1998; Li et al., 2000),
whereas the bax
 / bak
 /  cells are resistant to virtually all
death stimuli in a prolonged manner (Lindsten et al., 2000;
Cheng et al., 2001; Wei et al., 2001; Zong et al., 2001).
Consistent with this theory is the finding that Bcl-2 overex-
pression inhibits broader death pathways than deficiency of
Apaf-1 and caspase 9 (Marsden et al., 2002).
The ER is the main intracellular storage compartment for
Ca
2 , which is an important secondary messenger that is re-
quired for numerous cellular functions. Apoptosis occurs
upon the perturbation of cellular Ca
2  homeostasis, such as
cytosolic Ca
2  overload, ER Ca
2  depletion, and mitochon-
drial Ca
2  increase. The close physical contact of mitochon-
dria and the ER results in a higher exposure to Ca
2  of mito-
chondria than the rest of the cytosol, when Ca
2  is released
from the ER (Rizzuto et al., 1998). Bcl-2 family proteins
have been previously implicated in controlling apoptosis by
affecting cellular Ca
2  homeostasis. Overexpression of Bcl-2
leads to reduced mitochondrial Ca
2  stores and enhanced
ER sequestration, whereas overexpression of either wild-type
Bax or Bak has the opposite effect (Pinton et al., 2000; Pan
et al., 2001; Abeele et al., 2002; Li et al., 2002; Nutt et al.,
2002a,b). This has been interpreted to mean that Bax and
Bak interfere with mitochondrial Ca
2  homeostasis or ini-
tiate apoptosis by affecting the function of the mitochon-
drial permeability transition pore. The present data suggest
that Bax and Bak localized to the ER can directly affect ER
Ca
2  stores. In bax
 / bak
 /   cells, targeting the Bak-cb5
mutant to the ER resulted in acute ER Ca
2  depletion, indi-
cating a direct effect of the multidomain proapoptotic pro-
Figure 7. ER-targeted Bak can induce selective cleavage of cas-
pase 12, but not of caspase 7. bax
 / bak
 /  cells were infected 
with GFP vector control, Bak-IRES-GFP, Bak-ActA-IRES-GFP, 
Bak-cb5-IRES-GFP, and Bak- C-IRES-GFP at a high multiplicity. 
After infection, cells were lysed. Caspase 12, caspase 7, or PARP 
were detected by immunoblotting using respective antibodies.T
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teins on ER Ca
2  stores (Fig. 5). The effect on ER Ca
2  ap-
pears to result from the fact that the ER-targeted Bak-cb5
protein undergoes activation directly upon insertion in the
ER membrane, as demonstrated by its adopting an active
Bak configuration when introduced into cells by retroviral
infection. In contrast, secondary factors, such as endogenous
BH3-only proteins, must activate wild-type Bak, as it retains
an inactivated configuration and does not induce significant
Ca
2  release. When apoptosis is initiated in wild-type Bak–
expressing cells, it induces a mixture of events associated
with apoptosis from the two targeted Bak constructs.
In mitochondria-initiated apoptosis, the activation of Bax
and Bak involves BH3-only proteins. The presence of several
BH3-only proteins, such as tBid, Bim, Noxa, and Puma, at
mitochondria when apoptosis is triggered has suggested that
the activation of Bax/Bak by BH3-only proteins may take
place at this site (Li et al., 1998; Luo et al., 1998; Puthalakath
et al., 1999; Oda et al., 2000; Nakano and Vousden, 2001;
Yu et al., 2001). It is possible that some of the BH3-only pro-
teins may also localize to the ER and trigger Bax and Bak ac-
tivation at the ER, as suggested by recent findings that the
ER localization of the BH3-only protein BIK/NBK was in-
duced by apoptotic stimuli, and that a BIK/NBK mutant
specifically targeted to the ER retained the capability of in-
ducing cytochrome c release and apoptosis (Germain et al.,
2002; Mathai et al., 2002). It is of interest to determine
whether other BH3-only proteins can also function at the ER
and whether novel ER-specific BH3-only proteins may exist.
Caspase 12 has been demonstrated to be specifically local-
ized to the ER (Nakagawa et al., 2000). Although a required
role for caspase 12 in the induction of apoptosis has not
been established, the finding that caspase 12 cleavage is de-
pendent on Bax and Bak suggests that caspase 12 processing
lies downstream of Bax and Bak. Interestingly, expression of
the ER-targeted Bak-cb5 resulted in a significant increase in
caspase 12 processing, whereas expression of wild-type or the
mitochondrial Bak-ActA resulted in preferential cleavage of
caspase 7 and PARP. These data suggest that in addition to
their role in mitochondrial apoptosis, Bax and Bak localized
to the ER can initiate an alternative pathway of caspase acti-
vation that results in selective caspase 12 activation (Fig. 8).
As in mitochondria, Bax/Bak may initiate apoptosis from
the ER by inducing the release of apoptogenic factors from
the ER lumen into the cytosol. Although we have observed
selective ER Ca
2  depletion by the ER-targeted Bak, a num-
ber of additional molecules sequestered in the ER may also
be released and contribute to the initiation of apoptosis.
Based on recent identification of a number of mitochondrial
intermembrane proteins, which act as proapoptotic factors
when released into the cytosol, it will be important in the fu-
ture to pursue the possibility that other ER-sequestered fac-
tors may contribute to the apoptotic pathway initiated by
the activation of Bax and Bak localized to the ER.
Materials and methods
Cell culture
Wild-type and bax
 / bak
 /  murine fibroblasts were immortalized by
spontaneous immortalization. MEF, MCF7, and Phoenix cells were cul-
tured in DME supplemented with 10% FBS, 100 U/ml penicillin, and 100
 g/ml streptomycin.
DNA constructs
Murine Bak cDNA was cloned into pBabeMN-IRES-GFP to generate plas-
mid pBabe-Bak-GFP (Bak-IRES-GFP). A stop codon was introduced after
amino acid 183 by PCR to generate plasmid pBabe-Bak- C-IRES-GFP
(Bak- C-IRES-GFP). Cb5 and ActA DNA fragments (Zhu et al., 1996) were
generated by PCR and subsequently subcloned after amino acid 183 to
make pBabe-Bak-cb5-IRES-GFP (Bak-cb5-IRES-GFP) and pBabe-Bak-ActA-
IRES-GFP (Bak-ActA-IRES-GFP), respectively. Plasmids used for localiza-
tion experiments were made by subcloning appropriate DNA fragments
from pBabeMN-IRES-GFP into pEGFP-C1 (CLONTECH Laboratories, Inc.).
Expression constructs for caspase 3 (pBK5-caspase 3) and caspase 9
(pBK5-caspase 9) are a gift from X. Yang (University of Pennsylvania, Phil-
adelphia, PA). Expression constructs for caspase 12 (pcDNA3.1-caspase
12) and t-caspase 12 (pcDNA3.1-t-caspase 12) were previously described
(Nakagawa and Yuan, 2000).
Retroviral infection
Phoenix packaging cells were transfected with retroviral constructs. Viral
supernatants were collected during the 48–96-h period after transfection
and centrifuged at 2,000 rpm for 10 min to remove contaminating packag-
ing cells. MEFs were infected with the viral supernatant in the presence of
10  g/ml of polybrene (Sigma-Aldrich).
Cell death assay
Cells were retrovirally infected with GFP or Bak mutant–GFP. 48 h after in-
fection, a total of 1  g/ml DAPI was added to cell culture. Cells were ob-
served and photographed with the Nikon Eclipse TE300 microscope and
subjected to flow cytometry to determine the number of DAPI-positive
cells over that of GFP-positive cells. In transient transfection assays, cells
were transfected with 0.3  g pEGFP together with 1.8  g pBK5-caspase 3,
pBK5-caspase 9, pcDNA3.1-caspase 12, or pcDNA3.1-t-caspase 12 using
Geneporter2 transfection reagent (Gene Therapy Systems). 24 h later, cells
were stained with 1  g/ml DAPI, and the percentage of cell death was de-
termined by the ratio of DAPI-positive cells to GFP-positive cells.
Immunoelectronic microscopy
Cells were rinsed briefly with prewarmed serum-free medium and then
fixed with 2% paraformaldehyde and 0.05% glutaraldehyde for 30 min.
Cells were collected to make a pellet by centrifugation, washed with PBS,
and dehydrated at  25 C with ethanol. Cells were infiltrated with a mix-
ture of ethanol/Lowicryl K4M medium, embedded in pure Lowicryl K4M,
and polymerized at  25 C for 5 d with UV light at 365 nm. Ultrathin sec-
tions (80 nm) were cut with a diamond knife, mounted on Formvar-coated
thin-bar nickel grids, and labeled with established protocols (Allen et al.,
1996) using the antibodies against Bax (6A7; BD Biosciences) and Bak
(NT; Upstate Biotechnology).
Figure 8. Bax and Bak localized to the ER can initiate apoptosis. 
In addition to their mitochondrial localization and activity, Bax and 
Bak also reside at the ER. Upon ER stress treatment, Bax and Bak 
can initiate apoptosis from the ER.T
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Subcellular fractionation
Cells were resuspended in hypotonic buffer A (250 mM sucrose, 20 mM
Hepes, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 
protease inhibitor complex [Roche]) on ice for 30 min. Cells were dis-
rupted by passing through 26-gauge needles 30 times, and then 30-gauge
needles 20 times. Cell lysates were centrifuged at 750 g for 10 min at 4 C
to get rid of unlysed cells and nuclei. The supernatant was centrifuged at
10,000 g for 20 min at 4 C. The pellet was saved as the HM (mitochondria)
fraction. The supernatant was centrifuged at 100,000 g for 1 h at 4 C. The
supernatant was saved as the S-100 (cytosol) fraction and the pellet as the
LM (ER/microsome) fraction. The HM and LM fractions were lysed in RIPA
buffer (1% sodium deoxycholine, 0.1% SDS, 1% Triton X-100, 10 mM
Tris, pH 8.0, 0.14 M NaCl) for Western blotting. For Fig. 1 B, a mouse liver
was homogenized in buffer A with four strokes using Dounce homoge-
nizer. The lysate was centrifuged at 750 g for 10 min at 4 C to get rid of
unlysed cells and nuclei. The postnuclei supernatant was centrifuged at
6,000 g for 30 min to obtain the pellet as crude mitochondria. Crude mito-
chondria were resuspended in 0.5 ml buffer A, top loaded to a 1–2 M con-
tinuous sucrose gradient, and centrifuged at 25,000 rpm in an SW28 rotor
for 90 min. Fractions were collected using a 16G needle into collection
tubes at a rate of 0.75 ml/tube. The postmitochondrial supernatant was ad-
justed with 2.5 M sucrose to the final concentration of 1.8 M and bottom
loaded into an SW41 centrifuge tube. 1.5 ml each of 1.5, 1.3, 1.0, 0.86,
and 0.25 M sucrose was added to fill the centrifuge tube. The sample was
centrifuged at 41,000 rpm for 6 h at 4 C. The material formed at the inter-
face between the 1.5 and 1.8 M sucrose layers was collected. All fractions
were diluted with threefold buffer A and centrifuged at 41,000 rpm for 90
min in an SW55 rotor. Pellets were dissolved in 100  l RIPA buffer. 10  l
of each fraction was loaded into a 4–12% NuPAGE gradient gel for immu-
noblotting analysis.
Measurement of [Ca
2 ]i
Cells were resuspended in RPMI medium 1640 with 1% FBS and loaded
with 3  M Indo-1 (Molecular Probes) in the presence of 4 mM probenecid
at 37 C for 30 min. Loaded cells were washed twice and resuspended in
HBSS without calcium (Invitrogen). The measurement of cytosolic free
Ca
2  concentration ([Ca
2 ]i) was performed on an LSR flow cytometer
(Becton Dickinson). In brief, 2 min before analysis, EGTA was added to
each sample to a final concentration of 1.5 mM. After stable basal [Ca
2 ]i
was achieved, cells were treated with thapsigargin (5  M) to release the ER
Ca
2  pool. Data analysis was performed by using FlowJo software (Tree
Star), and [Ca
2 ]i was calculated from the equation [Ca
2 ]i   Kd   (R  
Rmin)   F(    475)min/(Rmax   R)   F(    475)max, where the values of Rmin, Rmax,
Fmin, and Fmax were determined by in situ calibration. Indo-1–loaded cells
were resuspended in RPMI.
Detection of Bax and Bak conformational changes
Analysis of the conformational changes of Bax and Bak was performed as de-
scribed previously (Griffiths et al., 1999; Mandic et al., 2001). Cells were
treated with thapsigargin (2  M) or tunicamycin (5  g/ml) for 48 h. Cells
were fixed in 0.25% paraformaldehyde in PBS for 5 min. Cells were washed
three times with PBS and incubated with 1:50 anti–mouse IgG1 (BD Bio-
sciences), anti-Bax (clone 6A7; BD Biosciences), anti-Bak (AM03; Oncogene
Research Products), or anti-Bak (NT; Upstate Biotechnology) in 100  g/ml
digitonin in PBS for 30 min. After being washed with PBS three times, cells
were incubated with 1:100 FITC-conjugated anti–mouse Ig and 1  g/ml
DAPI for 30 min. Cells were subjected to analysis using an LSR cytometer.
Chemical cross-linking
Wild-type MEFs or NIH3T3 cells were treated with brefeldin A (10  g/ml),
thapsigargin (2  M), or tunicamycin (1  g/ml) for 24 h. Cells were har-
vested and disrupted with 26-gauge needles. The cell lysates were incu-
bated with 5 mM BMH (Pierce Chemical Co.) for 30 min at room tempera-
ture. Subcellular fractionation was performed to obtain HM and LM
pellets. The pellets were lysed in RIPA buffer for immunoblotting.
Immunoblotting and immunofluorescence
20  g of total protein was resolved in precast 4–12% NuPAGE gradient
gels. Immunoblotting was performed by use of antibodies against Bax
(N-20; Santa Cruz Biotechnology, Inc.), Bak (Upstate Biotechnology), COX
IV (Molecular Probes), Tom40 (Santa Cruz Biotechnology, Inc.), calnexin
(C-20; Santa Cruz Biotechnology, Inc.), caspase 12, and CHOP (B-3; Santa
Cruz Biotechnology, Inc.). For immunofluorescence, cells were fixed in
4% paraformaldehyde and permeabilized for 10 min in PBS containing
0.2% Triton X-100. Cells were washed with PBS containing 0.02% Triton
X-100 and 1.5% FBS, followed by incubation with antibodies against COX
IV or calnexin (Santa Cruz Biotechnology, Inc.) for 1 h at room tempera-
ture. Cells were incubated with rhodamine red– or FITC-conjugated sec-
ondary antibodies (Jackson ImmunoResearch Laboratories). Nuclei were
visualized by staining with 1  g/ml DAPI. Images were captured on a 510
LSM confocal microscope (Carl Zeiss MicroImaging, Inc.).
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